You have 9 free searches left this month | for more free features.

Condition

Advanced Solid Tumors (2)

Glioblastoma (1)

Recurrent Glioblastoma (1)

Overall Status

Completed (2)

Active, not recruiting (1)

Sign in for free

Phase

phase 1 (3)

Sponsor

Astellas Pharma Global Development, Inc. (1)

Astellas Pharma Inc (1)

Dana-Farber Cancer Institute (1)

Collaborator

Astellas Pharma Inc (1)

Merck Sharp & Dohme LLC (1)

Regeneron Pharmaceuticals (1)

Intervention

asp8374 (3)

cemiplimab (1)

pembrolizumab (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

asp8374

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Glioblastoma, Recurrent Glioblastoma Trial in United States (ASP8374, cemiplimab)

Active, not recruiting

Glioblastoma
Recurrent Glioblastoma

ASP8374
cemiplimab

Boston, Massachusetts
+3 more

Jan 13, 2023

Advanced Solid Tumors Trial in Chuo-ku (ASP8374)

Completed

Advanced Solid Tumors

ASP8374

Chuo-ku, Tokyo, Japan

Site JP81001

May 21, 2021

Advanced Solid Tumors Trial in Worldwide (ASP8374, Pembrolizumab)

Completed

Advanced Solid Tumors

ASP8374
Pembrolizumab

Scottsdale, Arizona
+53 more

May 18, 2022